Literature DB >> 20623098

Molecular circuits of resolution in airway inflammation.

Troy Carlo1, Bruce D Levy.   

Abstract

Inflammatory diseases of the lung are common, cause significant morbidity, and can be refractory to therapy. Airway responses to injury, noxious stimuli, or microbes lead to leukocyte recruitment for host defense. As leukocytes respond, they interact with lung resident cells and can elaborate specific mediators that are enzymatically generated from polyunsaturated fatty acids via transcellular biosynthesis. These bioactive, lipid-derived, small molecules serve as agonists at specific receptors and are rapidly inactivated in the local environment. This review will focus on the biosynthesis, receptors, cellular responses, and in vivo actions of lipoxins, resolvins, and protectins as exemplary molecular signaling circuits in the airway that are anti-inflammatory and proresolving.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623098      PMCID: PMC3070155          DOI: 10.1100/tsw.2010.143

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  97 in total

Review 1.  Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.

Authors:  Charles N Serhan
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

2.  Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution.

Authors:  Eric L Campbell; Nancy A Louis; Sarah E Tomassetti; Geraldine O Canny; Makoto Arita; Charles N Serhan; Sean P Colgan
Journal:  FASEB J       Date:  2007-05-11       Impact factor: 5.191

3.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes.

Authors:  Jan M Schwab; Nan Chiang; Makoto Arita; Charles N Serhan
Journal:  Nature       Date:  2007-06-14       Impact factor: 49.962

4.  Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.

Authors:  Yee-Ping Sun; Sungwhan F Oh; Jasim Uddin; Rong Yang; Katherine Gotlinger; Eric Campbell; Sean P Colgan; Nicos A Petasis; Charles N Serhan
Journal:  J Biol Chem       Date:  2007-01-23       Impact factor: 5.157

5.  Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking.

Authors:  C Bandeira-Melo; P T Bozza; B L Diaz; R S Cordeiro; P J Jose; M A Martins; C N Serhan
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines.

Authors:  Krishnan Parameswaran; Katherine Radford; Adrian Fanat; Jancy Stephen; Caroline Bonnans; Bruce D Levy; Luke J Janssen; P Gerard Cox
Journal:  Am J Respir Cell Mol Biol       Date:  2007-04-12       Impact factor: 6.914

7.  Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.

Authors:  Makoto Arita; Taisuke Ohira; Yee-Ping Sun; Siva Elangovan; Nan Chiang; Charles N Serhan
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

8.  Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model.

Authors:  Dae Yong Kim; Su Youn Ryu; Ji Eun Lim; Yun Song Lee; Jai Youl Ro
Journal:  Eur J Pharmacol       Date:  2006-11-15       Impact factor: 4.432

9.  Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation.

Authors:  Driss El Kebir; Levente József; Tarek Khreiss; Wanling Pan; Nicos A Petasis; Charles N Serhan; János G Filep
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

10.  Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity.

Authors:  G E Celik; F O Erkekol; Z Misirligil; M Melli
Journal:  Clin Exp Allergy       Date:  2007-10       Impact factor: 5.018

View more
  5 in total

1.  The Autodigestion Hypothesis in Shock and Multi-Organ Failure: Degrading Protease Activity.

Authors:  Geert W Schmid-Schönbein; Alex Penn; Erik Kistler
Journal:  Bol Soc Port Hemorreol Microcirc       Date:  2011-07

2.  E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae.

Authors:  David M Aronoff; Ingrid L Bergin; Casey Lewis; Deepti Goel; Edmund O'Brien; Marc Peters-Golden; Peter Mancuso
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-04-02       Impact factor: 3.072

3.  An investigation of the resolution of inflammation (catabasis) in COPD.

Authors:  Aina Noguera; Cristina Gomez; Rosa Faner; Borja Cosio; Ana González-Périz; Joan Clària; Angel Carvajal; Alvar Agustí
Journal:  Respir Res       Date:  2012-11-13

Review 4.  Regulatory mechanisms of neutrophil migration from the circulation to the airspace.

Authors:  Wan-Chi Lin; Michael B Fessler
Journal:  Cell Mol Life Sci       Date:  2021-02-05       Impact factor: 9.261

5.  Altered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia.

Authors:  Olaf Eickmeier; Su Youn Kim; Eva Herrmann; Constanze Döring; Ruth Duecker; Sandra Voss; Sibylle Wehner; Christoph Hölscher; Julia Pietzner; Stefan Zielen; Ralf Schubert
Journal:  BMC Pulm Med       Date:  2014-05-29       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.